Congress Pre-Course - 10th European Lupus Meeting

General Information
The Congress Pre-Course on October 5 is included in the registration fee of the Congress but has a
limited number of participants. For those will not attend the congress, the pre-course has a cost of
€ 120,00. Please check your name at the registration desk.
The Congress Pre-Course is supported
by an unrestricted educational grant of
ACCREDITAMENTO ECM
Il Congress Pre-Course è stato accreditato presso la Commissione Nazionale per la Formazione
Continua con Obiettivo Formativo di Processo “Documentazione Clinica. Percorsi clinicoassistenziali diagnostici e riabilitativi, profili di assistenza – profili di cura (3)” per la figura professionale
del Medico Chirurgo con specializzazione nelle seguenti discipline: allergologia ed immunologia
clinica; cardiologia; genetica medica; geriatria; malattie metaboliche e diabetologia; malattie
dell’apparato respiratorio; malattie infettive; medicina fisica e riabilitazione; medicina interna;
medicina termale; nefrologia; pediatria; reumatologia; ortopedia e traumatologia; anatomia
patologica; anestesia e rianimazione; biochimica clinica; farmacologia e tossicologia clinica;
medicina legale; patologia clinica (laboratorio di analisi chimico-cliniche e microbiologia);
medicina generale (medici di famiglia); continuità assistenziale; pediatria (pediatri di libera
scelta); per un numero massimo di n. 450 partecipanti.
10
th
Alfa Wassermann fa parte del gruppo Alfasigma
EUROPEAN
LUPUS
MEETING
Oltre tale numero e per professioni/discipline differenti da quelle accreditate non sarà possibile
rilasciare i crediti formativi.
Si precisa che i crediti verranno erogati a fronte di una partecipazione del 100% ai lavori scientifici e
del superamento della prova di apprendimento con almeno il 75% delle risposte corrette.
La verifica della presenza verrà effettuato tramite firma su apposito registro. Tali firme dovranno
essere apposte in entrata e in uscita.
L’EVENTO HA OTTENUTO N. 2,5 CREDITI FORMATIVI – ID ECM: 93-165765 – ED. 1
CME PROVIDER
AIM Education - Provider n. 93
Via G. Ripamonti, 129 - 20141 Milan, Italy
Ph. +39 02 56601.1 - Fax +39 02 70048585
[email protected]
www.aimeducation.it
ORGANIZING SECRETARIAT
AIM Group International - Milan Office
Via G. Ripamonti, 129 - 20141 Milan, Italy
Ph. +39 02 566011 - Fax. +39 02 70048578
[email protected]
www.lupus2016.org
Congress
Pre-Course
VENICE
2016
5-8 October
Palazzo del Casinò
1
Welcome
Congress Pre-Course Scientific Program
Congress Pre-Course Scientific Program
Dear Colleagues
WEDNESDAY 5 OCTOBER, 2016
WEDNESDAY 5 OCTOBER, 2016
The landscape of therapeutics in autoimmune rheumatic diseases has been evolving in recent
Perla Room
Party Room
years, probably owing to emerging concepts that are wisely changing their management.
Indeed, rheumatologists advocate the need for preventive strategies, treat-to-target approaches
and targeted therapies, as well as the importance of remission and steroid tapering, which have
influenced recent clinical research on novel drugs. In turn, the roots of targeted therapy are
plunged into the knowledge on disease mechanisms of development, which makes it indispensable
for a modern rheumatologist to enjoy basic immunology. Although basic and clinical researches
are providing encouraging results for any disease, the most relevant advances currently concern
inflammatory arthropathies, being either rheumatoid arthritis or seronegative arthritis, and SLE.
12.45-13.00
WELCOME AND INTRODUCTION
A. Doria (Padova, Italy), A. Tincani (Brescia, Italy),
P. Sarzi-Puttini (Milano, Italy)
Perla Room
Use of the guidelines for a proper diagnosis
E. Lubrano di Scorpaniello (Campobasso, Italy)
13.00-15.30
Autoimmunity and tolerance: two sides of the same coin
S. Sozzani (Brescia, Italy), D. Bosisio (Brescia, Italy)
14.20-15.00
Undifferentiated spondiloarthropathis: still a therapeutic dilemma
P. Leccese (Potenza, Italy), I. Olivieri (Potenza, Italy)
15.00-15.30
General Discussion
15.30-16.00 Coffee Break
arthritis and seronegative arthritis and going over challenges in classification and diagnosis,
General Discussion
patient stratification and treatment strategies pointing to the best clinical success.
Casinò Room
Each of the three sessions will be subdivided into two sub-sessions and followed by a general
13.00-18.30
specialist.
So, a warm welcome to the 10th Lupus Meeting pre-course and to this journey together.
Prof. Piercarlo Sarzi-Puttini
Prof. Andrea Doria
Prof. Angela Tincani
Psoriasis and psoriatic arthritis: an autoimmune or autoinflammatory disease?
C.F. Selmi (Milano, Italy)
13.40-14.20
18.00-18.30
discussion, that will hopefully tantalize anyone of you, being either a resident or an experienced
13.00-13.40
THE IMMUNOLOGY OF LUPUS
Chairs: A. Doria (Padova, Italy), A. Tincani (Brescia, Italy)
Immunopathogenesis and treatment of lupus
S. Sozzani (Brescia, Italy), D. Bosisio (Brescia, Italy)
these issues, highlighting recent advances in immunology and development of SLE, rheumatoid
PSORIATIC ARTHRITIS / SPONDILOARTHROPATHIES:
NEW PATHWAYS, NEW TREATMENTS
Chairs: L. Punzi (Padova, Italy), C. Salvarani (Reggio Emilia)
13.00-18.30
16.00-18.00
Hence, the 10th European Lupus Meeting pre-course on Wednesday afternoon will deal with all of
13.00-18.30
15.30-16.00 Coffee Break
16.00-16.40
Treatment of the psoriatic diseases: what is relevant?
A. Marchesoni (Milano, Italy)
16.40-17.20
Anti-TNF agents in psoriasis and psoriatic arthritis
C. Salvarani (Reggio Emilia, Italy)
RHEUMATOID ARTHRITIS: DIAGNOSIS AND TREATMENT
Chairs: M. Galeazzi (Siena, Italy), C. Montecucco (Pavia, Italy)
17.20-18.00
Comorbidities in psoriatic arthritis and spondiloarthropathies
F. Atzeni (Milano, Italy)
13.00-13.40
Biomarkers and subgrouping of patients: is it relevant?
G. Ferraccioli (Roma, Italy)
18.00-18.30
General Discussion
13.40-14.20
Role of metotrexato and other non-biologic DMARDs
P. Ostuni (Padova, Italy)
14.20-15.00
Treatment of early and established RA
L. Sinigaglia (Milano, Italy)
15.00-15.30
General Discussion
15.30-16.00 Coffee Break
16.00-16.40
De-escalation and spacing: what is behind remission and low disease activity
R. Caporali (Pavia, Italy)
16.40-17.20
Biosimilars: different or just the same?
P. Sarzi-Puttini (Milano, Italy)
17.20-18.00
Transition clinic: from juvenile idiopathic arthritis to adult idiopathic arthritis
F. Zulian (Padova, Italy)
18.00-18.30
General Discussion
Welcome
Congress Pre-Course Scientific Program
Congress Pre-Course Scientific Program
Dear Colleagues
WEDNESDAY 5 OCTOBER, 2016
WEDNESDAY 5 OCTOBER, 2016
The landscape of therapeutics in autoimmune rheumatic diseases has been evolving in recent
Perla Room
Party Room
years, probably owing to emerging concepts that are wisely changing their management.
12.45-13.00
Indeed, rheumatologists advocate the need for preventive strategies, treat-to-target approaches
and targeted therapies, as well as the importance of remission and steroid tapering, which have
influenced recent clinical research on novel drugs. In turn, the roots of targeted therapy are
plunged into the knowledge on disease mechanisms of development, which makes it indispensable
for a modern rheumatologist to enjoy basic immunology. Although basic and clinical researches
are providing encouraging results for any disease, the most relevant advances currently concern
inflammatory arthropathies, being either rheumatoid arthritis or seronegative arthritis, and SLE.
WELCOME AND INTRODUCTION
A. Doria (Padova, Italy), A. Tincani (Brescia, Italy),
P. Sarzi-Puttini (Milano, Italy)
Perla Room
Use of the guidelines for a proper diagnosis
E. Lubrano di Scorpaniello (Campobasso, Italy)
13.00-15.30
Autoimmunity and tolerance: two sides of the same coin
S. Sozzani (Brescia, Italy), D. Bosisio (Brescia, Italy)
14.20-15.00
Undifferentiated spondiloarthropathis: still a therapeutic dilemma
P. Leccese (Potenza, Italy), I. Olivieri (Potenza, Italy)
15.00-15.30
General Discussion
15.30-16.00 Coffee Break
arthritis and seronegative arthritis and going over challenges in classification and diagnosis,
General Discussion
patient stratification and treatment strategies pointing to the best clinical success.
Casinò Room
Each of the three sessions will be subdivided into two sub-sessions and followed by a general
13.00-18.30
specialist.
So, a warm welcome to the 10th Lupus Meeting pre-course and to this journey together.
Prof. Piercarlo Sarzi-Puttini
Prof. Andrea Doria
Prof. Angela Tincani
Psoriasis and psoriatic arthritis: an autoimmune or autoinflammatory disease?
C.F. Selmi (Milano, Italy)
13.40-14.20
18.00-18.30
discussion, that will hopefully tantalize anyone of you, being either a resident or an experienced
13.00-13.40
THE IMMUNOLOGY OF LUPUS
Chairs: A. Doria (Padova, Italy), A. Tincani (Brescia, Italy)
Immunopathogenesis and treatment of lupus
S. Sozzani (Brescia, Italy), D. Bosisio (Brescia, Italy)
these issues, highlighting recent advances in immunology and development of SLE, rheumatoid
PSORIATIC ARTHRITIS / SPONDILOARTHROPATHIES:
NEW PATHWAYS, NEW TREATMENTS
Chairs: L. Punzi (Padova, Italy), C. Salvarani (Reggio Emilia)
13.00-18.30
16.00-18.00
Hence, the 10th European Lupus Meeting pre-course on Wednesday afternoon will deal with all of
13.00-18.30
15.30-16.00 Coffee Break
16.00-16.40
Treatment of the psoriatic diseases: what is relevant?
A. Marchesoni (Milano, Italy)
16.40-17.20
Anti-TNF agents in psoriasis and psoriatic arthritis
C. Salvarani (Reggio Emilia, Italy)
RHEUMATOID ARTHRITIS: DIAGNOSIS AND TREATMENT
Chairs: M. Galeazzi (Siena, Italy), C. Montecucco (Pavia, Italy)
17.20-18.00
Comorbidities in psoriatic arthritis and spondiloarthropathies
F. Atzeni (Milano, Italy)
13.00-13.40
Biomarkers and subgrouping of patients: is it relevant?
G. Ferraccioli (Roma, Italy)
18.00-18.30
General Discussion
13.40-14.20
Role of metotrexato and other non-biologic DMARDs
P. Ostuni (Padova, Italy)
14.20-15.00
Treatment of early and established RA
L. Sinigaglia (Milano, Italy)
15.00-15.30
General Discussion
15.30-16.00 Coffee Break
16.00-16.40
De-escalation and spacing: what is behind remission and low disease activity
R. Caporali (Pavia, Italy)
16.40-17.20
Biosimilars: different or just the same?
P. Sarzi-Puttini (Milano, Italy)
17.20-18.00
Transition clinic: from juvenile idiopathic arthritis to adult idiopathic arthritis
F. Zulian (Padova, Italy)
18.00-18.30
General Discussion
Welcome
Congress Pre-Course Scientific Program
Congress Pre-Course Scientific Program
Dear Colleagues
WEDNESDAY 5 OCTOBER, 2016
WEDNESDAY 5 OCTOBER, 2016
The landscape of therapeutics in autoimmune rheumatic diseases has been evolving in recent
Perla Room
Party Room
years, probably owing to emerging concepts that are wisely changing their management.
12.45-13.00
Indeed, rheumatologists advocate the need for preventive strategies, treat-to-target approaches
and targeted therapies, as well as the importance of remission and steroid tapering, which have
influenced recent clinical research on novel drugs. In turn, the roots of targeted therapy are
plunged into the knowledge on disease mechanisms of development, which makes it indispensable
for a modern rheumatologist to enjoy basic immunology. Although basic and clinical researches
are providing encouraging results for any disease, the most relevant advances currently concern
inflammatory arthropathies, being either rheumatoid arthritis or seronegative arthritis, and SLE.
WELCOME AND INTRODUCTION
A. Doria (Padova, Italy), A. Tincani (Brescia, Italy),
P. Sarzi-Puttini (Milano, Italy)
Perla Room
Use of the guidelines for a proper diagnosis
E. Lubrano di Scorpaniello (Campobasso, Italy)
13.00-15.30
Autoimmunity and tolerance: two sides of the same coin
S. Sozzani (Brescia, Italy), D. Bosisio (Brescia, Italy)
14.20-15.00
Undifferentiated spondiloarthropathis: still a therapeutic dilemma
P. Leccese (Potenza, Italy), I. Olivieri (Potenza, Italy)
15.00-15.30
General Discussion
15.30-16.00 Coffee Break
arthritis and seronegative arthritis and going over challenges in classification and diagnosis,
General Discussion
patient stratification and treatment strategies pointing to the best clinical success.
Casinò Room
Each of the three sessions will be subdivided into two sub-sessions and followed by a general
13.00-18.30
specialist.
So, a warm welcome to the 10th Lupus Meeting pre-course and to this journey together.
Prof. Piercarlo Sarzi-Puttini
Prof. Andrea Doria
Prof. Angela Tincani
Psoriasis and psoriatic arthritis: an autoimmune or autoinflammatory disease?
C.F. Selmi (Milano, Italy)
13.40-14.20
18.00-18.30
discussion, that will hopefully tantalize anyone of you, being either a resident or an experienced
13.00-13.40
THE IMMUNOLOGY OF LUPUS
Chairs: A. Doria (Padova, Italy), A. Tincani (Brescia, Italy)
Immunopathogenesis and treatment of lupus
S. Sozzani (Brescia, Italy), D. Bosisio (Brescia, Italy)
these issues, highlighting recent advances in immunology and development of SLE, rheumatoid
PSORIATIC ARTHRITIS / SPONDILOARTHROPATHIES:
NEW PATHWAYS, NEW TREATMENTS
Chairs: L. Punzi (Padova, Italy), C. Salvarani (Reggio Emilia)
13.00-18.30
16.00-18.00
Hence, the 10th European Lupus Meeting pre-course on Wednesday afternoon will deal with all of
13.00-18.30
15.30-16.00 Coffee Break
16.00-16.40
Treatment of the psoriatic diseases: what is relevant?
A. Marchesoni (Milano, Italy)
16.40-17.20
Anti-TNF agents in psoriasis and psoriatic arthritis
C. Salvarani (Reggio Emilia, Italy)
RHEUMATOID ARTHRITIS: DIAGNOSIS AND TREATMENT
Chairs: M. Galeazzi (Siena, Italy), C. Montecucco (Pavia, Italy)
17.20-18.00
Comorbidities in psoriatic arthritis and spondiloarthropathies
F. Atzeni (Milano, Italy)
13.00-13.40
Biomarkers and subgrouping of patients: is it relevant?
G. Ferraccioli (Roma, Italy)
18.00-18.30
General Discussion
13.40-14.20
Role of metotrexato and other non-biologic DMARDs
P. Ostuni (Padova, Italy)
14.20-15.00
Treatment of early and established RA
L. Sinigaglia (Milano, Italy)
15.00-15.30
General Discussion
15.30-16.00 Coffee Break
16.00-16.40
De-escalation and spacing: what is behind remission and low disease activity
R. Caporali (Pavia, Italy)
16.40-17.20
Biosimilars: different or just the same?
P. Sarzi-Puttini (Milano, Italy)
17.20-18.00
Transition clinic: from juvenile idiopathic arthritis to adult idiopathic arthritis
F. Zulian (Padova, Italy)
18.00-18.30
General Discussion
General Information
The Congress Pre-Course on October 5 is included in the registration fee of the Congress but has a
limited number of participants. For those will not attend the congress, the pre-course has a cost of
€ 120,00. Please check your name at the registration desk.
The Congress Pre-Course is supported
by an unrestricted educational grant of
ACCREDITAMENTO ECM
Il Congress Pre-Course è stato accreditato presso la Commissione Nazionale per la Formazione
Continua con Obiettivo Formativo di Processo “Documentazione Clinica. Percorsi clinicoassistenziali diagnostici e riabilitativi, profili di assistenza – profili di cura (3)” per la figura professionale
del Medico Chirurgo con specializzazione nelle seguenti discipline: allergologia ed immunologia
clinica; cardiologia; genetica medica; geriatria; malattie metaboliche e diabetologia; malattie
dell’apparato respiratorio; malattie infettive; medicina fisica e riabilitazione; medicina interna;
medicina termale; nefrologia; pediatria; reumatologia; ortopedia e traumatologia; anatomia
patologica; anestesia e rianimazione; biochimica clinica; farmacologia e tossicologia clinica;
medicina legale; patologia clinica (laboratorio di analisi chimico-cliniche e microbiologia);
medicina generale (medici di famiglia); continuità assistenziale; pediatria (pediatri di libera
scelta); per un numero massimo di n. 450 partecipanti.
10
th
Alfa Wassermann fa parte del gruppo Alfasigma
EUROPEAN
LUPUS
MEETING
Oltre tale numero e per professioni/discipline differenti da quelle accreditate non sarà possibile
rilasciare i crediti formativi.
Si precisa che i crediti verranno erogati a fronte di una partecipazione del 100% ai lavori scientifici e
del superamento della prova di apprendimento con almeno il 75% delle risposte corrette.
La verifica della presenza verrà effettuato tramite firma su apposito registro. Tali firme dovranno
essere apposte in entrata e in uscita.
L’EVENTO HA OTTENUTO N. 2,5 CREDITI FORMATIVI – ID ECM: 93-165765 – ED. 1
CME PROVIDER
AIM Education - Provider n. 93
Via G. Ripamonti, 129 - 20141 Milan, Italy
Ph. +39 02 56601.1 - Fax +39 02 70048585
[email protected]
www.aimeducation.it
ORGANIZING SECRETARIAT
AIM Group International - Milan Office
Via G. Ripamonti, 129 - 20141 Milan, Italy
Ph. +39 02 566011 - Fax. +39 02 70048578
[email protected]
www.lupus2016.org
Congress
Pre-Course
VENICE
2016
5-8 October
Palazzo del Casinò
1
General Information
The Congress Pre-Course on October 5 is included in the registration fee of the Congress but has a
limited number of participants. For those will not attend the congress, the pre-course has a cost of
€ 120,00. Please check your name at the registration desk.
The Congress Pre-Course is supported
by an unrestricted educational grant of
ACCREDITAMENTO ECM
Il Congress Pre-Course è stato accreditato presso la Commissione Nazionale per la Formazione
Continua con Obiettivo Formativo di Processo “Documentazione Clinica. Percorsi clinicoassistenziali diagnostici e riabilitativi, profili di assistenza – profili di cura (3)” per la figura professionale
del Medico Chirurgo con specializzazione nelle seguenti discipline: allergologia ed immunologia
clinica; cardiologia; genetica medica; geriatria; malattie metaboliche e diabetologia; malattie
dell’apparato respiratorio; malattie infettive; medicina fisica e riabilitazione; medicina interna;
medicina termale; nefrologia; pediatria; reumatologia; ortopedia e traumatologia; anatomia
patologica; anestesia e rianimazione; biochimica clinica; farmacologia e tossicologia clinica;
medicina legale; patologia clinica (laboratorio di analisi chimico-cliniche e microbiologia);
medicina generale (medici di famiglia); continuità assistenziale; pediatria (pediatri di libera
scelta); per un numero massimo di n. 450 partecipanti.
10
th
Alfa Wassermann fa parte del gruppo Alfasigma
EUROPEAN
LUPUS
MEETING
Oltre tale numero e per professioni/discipline differenti da quelle accreditate non sarà possibile
rilasciare i crediti formativi.
Si precisa che i crediti verranno erogati a fronte di una partecipazione del 100% ai lavori scientifici e
del superamento della prova di apprendimento con almeno il 75% delle risposte corrette.
La verifica della presenza verrà effettuato tramite firma su apposito registro. Tali firme dovranno
essere apposte in entrata e in uscita.
L’EVENTO HA OTTENUTO N. 2,5 CREDITI FORMATIVI – ID ECM: 93-165765 – ED. 1
CME PROVIDER
AIM Education - Provider n. 93
Via G. Ripamonti, 129 - 20141 Milan, Italy
Ph. +39 02 56601.1 - Fax +39 02 70048585
[email protected]
www.aimeducation.it
ORGANIZING SECRETARIAT
AIM Group International - Milan Office
Via G. Ripamonti, 129 - 20141 Milan, Italy
Ph. +39 02 566011 - Fax. +39 02 70048578
[email protected]
www.lupus2016.org
Congress
Pre-Course
VENICE
2016
5-8 October
Palazzo del Casinò
1